In a groundbreaking advance that heralds a new era in pediatric oncology, researchers at St. Jude Children’s Research Hospital have unveiled a promising therapeutic strategy to combat neuroblastoma, a devastating childhood cancer notorious for its complexity and resistance to treatment.
In a groundbreaking advance that heralds a new era in pediatric oncology, researchers at St. Jude Children’s Research Hospital have unveiled a promising therapeutic strategy to combat neuroblastoma, a devastating childhood cancer notorious for its complexity and resistance to treatment.
Gene expression governs whether neuroblastoma tumor cells exist in either the adrenergic (differentiated and sensitive to treatment) or mesenchymal (less differentiated and therapy-resistant) cell state.
Influential Women is proud to announce that Vanessa Morales-Tirado, PhD, will be honored as one of its featured honorees for 2025.
Influential Women is proud to announce that Vanessa Morales-Tirado, PhD, will be honored as one of its featured honorees for 2025.
Influential Women is proud to announce that Vanessa Morales-Tirado, PhD, will be honored as one of its featured honorees for 2025.
Influential Women is proud to announce that Vanessa Morales-Tirado, PhD, will be honored as one of its featured honorees for 2025.
Influential Women is proud to announce that Vanessa Morales-Tirado, PhD, will be honored as one of its featured honorees for 2025.
